Yale Hematology is pleased to welcome Ash Alpert, MD, MFA, (pronouns they/them) as an Instructor of Medicine (Hematology). Dr. Alpert recently completed their post-doctoral fellowship (T32) in health services research at the Brown University School of Public Health and will join Yale Cancer Center and Smilow Cancer Hospital on September 1, 2023.
Dr. Alpert received their medical degree from the University of Vermont Larner College of Medicine and completed residency at Cambridge Hospital and fellowship in Hematology and Medical Oncology at the Wilmot Cancer Institute of the University of Rochester Medical Center. Their clinical expertise is focused on the care of patients with lymphoma, with a particular interest in treating people with lymphoma living with HIV, and they will see patients in New Haven.
Dr. Alpert's research investigates community solutions to improving the experiences and outcomes of transgender people with cancer. They received a Young Investigator Award from Conquer Cancer, the American Society for Clinical Oncology (ASCO) Foundation to develop patient-centered and non-stigmatizing gender identity data collection methods to be implemented in oncology settings and investigate the connections between experiences of violence and cancer risk for transgender people. Dr. Alpert is also involved with advocacy efforts nationally including working with national oncology organizations such as the National Comprehensive Cancer Network and ASCO to implement structural changes to improve outcomes for transgender people with cancer.